Palliative-radiotherapy in lumbosacral carcinomatous neuropathy.
The authors report their own experience in obtaining pain relief in 13 recurrent or disseminated cancer patients affected by lumbosacral carcinomatous neuropathy (LCN). The site, where the disease involved the lumbosacral plexus or its branches, was palliatively irradiated with a few large fractions. The average duration of response was 196 days. Median survival (uncensored) was 185 days (range 47-636 days).
Russi
E G
EG
Department of Biomedical Technology (Radiobiomedical Research), IST, Genova, Italy.
Pergolizzi
S
S
Gaeta
M
M
Mesiti
M
M
D'Aquino
A
A
Delia
P
P
D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000150:complications*; D005260:Female; D006801:Humans; D008160:Lumbosacral Plexus / Q000528:radiation effects*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D009437:Neuralgia / Q000209:etiology* / Q000532:radiotherapy*; D010147:Pain Measurement; D010166:Palliative Care; D010386:Pelvic Neoplasms / Q000150:complications*; D011882:Radiotherapy, High-Energy; D012074:Remission Induction; D015996:Survival Rate; D013997:Time Factors